Stay updated on MAPP2 MDMA Therapy Clinical Trial
Sign up to get notified when there's something new on the MAPP2 MDMA Therapy Clinical Trial page.

Latest updates to the MAPP2 MDMA Therapy Clinical Trial page
- Check4 days agoChange DetectedThe addition of Qiryat Krinitzi, Israel as a study site expands the list of locations for participant enrollment. Tel Litwinsky, Israel has been removed from the list of participating sites.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a small page version update. No changes to the study content or data are indicated.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe study documents show a new revision (v3.6.5) replacing the previous v3.6.4, indicating an updated version of the study plan or related materials.SummaryDifference0.0%

- Check47 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, signaling a small internal update to the page’s documentation and versioning.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now shows a new revision label v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, signaling a small software update to the ClinicalTrials.gov page. No study data, content, or details appear to be changed as part of this update.SummaryDifference0.0%

Stay in the know with updates to MAPP2 MDMA Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAPP2 MDMA Therapy Clinical Trial page.